PHTEX Fees and Costs — Principal LifeTime Hybrid Income Fund, Class R-3

Data updated: 2026-09-25

The net expense ratio is 0.91% (0.95% before fee waivers). There are no sales loads or redemption fees. Portfolio turnover was 27%.

PHTEX Fees and Expenses

Annual operating expenses and sales charges of PHTEX. Prospectus, as of February 29, 2020.

Annual operating expenses
Management fee0.00%
12b-1 fee0.25%
Other expenses0.38%
Gross expense ratio0.95%
Fee waiver−0.04%
Net expense ratio0.91%
Sales charges
Max front load—
Max deferred load0.00%
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentNo

PHTEX Costs Over Time

On $10,000 invested in PHTEX, assuming 5% a year before costs, total costs come to $570 over 5 years, cutting the return by 0.96% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.91%)$96$298$518
Lost growth on money paid in costs$0$15$52
Total costs$96$313$570
Value after costs$10,404$11,263$12,193
Impact on return, per year0.96%0.96%0.96%

PHTEX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): $110.9M
  • Portfolio turnover (prospectus): 27%
  • Securities lending: none during the year

Principal LifeTime Hybrid Income Fund Share Classes

Net expense ratio and maximum front-end load of each share class, cheapest first.

TickerClassNet expense ratioFront load
PLTYXClass R-60.31%—
PHTFXInstitutional Class0.34%—
PHJFXClass J0.48%—
PHTEXClass R-30.91%—

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.